Senior Vice President, Technical Operations · OCULAR THERAPEUTIX, INC (OCUL)

Kevin Hanley

FY2018 is the first fiscal year CompBrief holds for Kevin Hanley as a named executive officer of OCULAR THERAPEUTIX; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$1,006,999

Salary $330,061Stock awards $0Bonus $152,425

3rd of 5 named executive officers at Ocular Therapeutix by FY2018 total.

5 named officers on file for OCULAR THERAPEUTIX, FY2018

Kevin Hanley’s pay file — $29

  • 1 fiscal year of pay, line by line
  • OCUL’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how OCULAR THERAPEUTIX’s whole pay program stands against its peers

  • OCULAR THERAPEUTIX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OCUL→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2019 (DEF 14A).

Free

Get Kevin Hanley’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Kevin Hanley compensation by year

OCULAR THERAPEUTIX Summary Compensation Table · the one fiscal year held
In US dollars, as OCULAR THERAPEUTIX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$330,061
Bonus$152,425
Stock awards$0
Option awards$523,763
Non-equity incentive$0
Pension and deferred compensation$0
All other$750
Total$1,006,999

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 25, 2019, accession 0001558370-19-003296, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OCULAR THERAPEUTIX, INC filed document, accession 0001558370-19-003296. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
Option125,000—$5.01

Per the Outstanding Equity Awards at Fiscal Year-End table in OCULAR THERAPEUTIX, INC's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

OCULAR THERAPEUTIX’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Antony MattessichPresident and Chief Executive Officer$2,625,529
Amarpreet SawhneyFormer Chairman of the Board$1,023,526
Kevin Hanley · this pageSenior Vice President, Technical Operations$1,006,999
Michael GoldsteinChief Medical Officer$901,072
Daniel BollagFormer Chief Strategy Officer$696,641

The full OCULAR THERAPEUTIX compensation record

free company brief

This page is one person within OCULAR THERAPEUTIX's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the OCULAR THERAPEUTIX proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OCULAR THERAPEUTIX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Kevin Hanley's compensation dossier · One-time report. No refunds.